Meeting to be held on April 20-24 hosted by Oppenheimer.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DSGN:
- Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
- Design Therapeutics management to meet with Oppenheimer
- Design Therapeutics Appoints David Shapiro to Board
- Design Therapeutics initiated with a Buy at Jefferies
- Design Therapeutics price target raised to $14 from $13 at RBC Capital
